Scancell SCNLF Stock
Scancell Price Chart
Scancell SCNLF Financial and Trading Overview
| Scancell stock price | 0.13 USD |
| Previous Close | 0.22 USD |
| Open | 0.22 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.22 - 0.22 USD |
| 52 Week Range | 0.1 - 0.59 USD |
| Volume | 100 USD |
| Avg. Volume | 0 USD |
| Market Cap | 180.05M USD |
| Beta (5Y Monthly) | 0.615325 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SCNLF Valuation Measures
| Enterprise Value | 164.79M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 34.158348 |
| Price/Book (mrq) | 11.578948 |
| Enterprise Value/Revenue | 31.263 |
| Enterprise Value/EBITDA | -15.934 |
Trading Information
Scancell Stock Price History
| Beta (5Y Monthly) | 0.615325 |
| 52-Week Change | 45.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.59 USD |
| 52 Week Low | 0.1 USD |
| 50-Day Moving Average | 0.22 USD |
| 200-Day Moving Average | 0.2 USD |
SCNLF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 818.4M |
| Float | 435.99M |
| Short Ratio | N/A |
| % Held by Insiders | 6.61% |
| % Held by Institutions | 49.03% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | October 31, 2022 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | -160.082% |
| Operating Margin (ttm) | -205.71% |
| Gross Margin | 100.00% |
| EBITDA Margin | -196.20% |
Management Effectiveness
| Return on Assets (ttm) | -16.30% |
| Return on Equity (ttm) | -44.27% |
Income Statement
| Revenue (ttm) | 5.27M USD |
| Revenue Per Share (ttm) | 0.006 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -10342000 USD |
| Net Income Avi to Common (ttm) | -8438000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.04M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 9.47M USD |
| Total Debt/Equity (mrq) | 61.41 USD |
| Current Ratio (mrq) | 11.451 |
| Book Value Per Share (mrq) | 0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9982000 USD |
| Levered Free Cash Flow (ttm) | -11050500 USD |
Profile of Scancell
| Country | United States |
| State | N/A |
| City | Oxford |
| Address | Bellhouse Building |
| ZIP | OX4 4GD |
| Phone | 44 18 6558 2066 |
| Website | https://www.scancell.co.uk |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Q&A For Scancell Stock
What is a current SCNLF stock price?
Scancell SCNLF stock price today per share is 0.13 USD.
How to purchase Scancell stock?
You can buy SCNLF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scancell?
The stock symbol or ticker of Scancell is SCNLF.
Which industry does the Scancell company belong to?
The Scancell industry is Biotechnology.
How many shares does Scancell have in circulation?
The max supply of Scancell shares is 945.49M.
What is Scancell Price to Earnings Ratio (PE Ratio)?
Scancell PE Ratio is now.
What was Scancell earnings per share over the trailing 12 months (TTM)?
Scancell EPS is -0.02 USD over the trailing 12 months.
Which sector does the Scancell company belong to?
The Scancell sector is Healthcare.